Passisd Laoveeravat

Advanced Inflammatory Bowel Disease Fellow @ Mayo Clinic, Florida

[AJG - The American Journal of Gastroenterology @AmJGastro]

Avoidant/Restrictive Eating in People With and Without Bowel Symptoms in the General Population: Prevalence, Clinical Profile, and Associated Factors
Blomsten, et al.

📕

[Edward Loftus @EdwardLoftus2]

The Twitterless Prof Sid Singh discussing medical therapy of fistulizing Crohn’s disease #SidSingh #AOCC2026 @MayoClinicGIHep Define, drainage, antibiotics, medical therapy. Use TOpClass for characterizing fistula

[Alex Leow @dralexleow]

Starting off the inaugural AOCC–IBUS Advanced Module 3 in Seoul! 🇰🇷 Great to reconnect with friends and colleagues from across the IUS community, and an honour to present "What's New in IUS in UC." Exciting times for intestinal ultrasound in Asia.

Wonderful faculty: Kayal Vizhi Nagarajan (India), Yoon-kyo An (Australia), Joyce Wing Yan Mak (Hong Kong), Kerri Novak (Canada), Sung Wook Hwang (Korea), Shintaro Sagami (Japan), Ryan Mathias (Australia) & Mariangela Allocca (Italy).

Congratulations for the wonderful meeting.

#AOCC2026 #ASIUS #bowelultrasonography @BowelUltrasound

[Neeraj Narula @NarulaNeeraj]

While many advanced therapies can induce response in UC, upadacitinib gets you there faster. Our recent article published in @AGA_CGH compares onset of efficacy of biologic and small molecules in bio-naive UC. https://t.co/wqbobxYYq3

[Seb @ibdseb]

Interested in Global 🌎 #IBD

We have a FREE in-person ( for 🇬🇧 HCPs) and online #IBD educational event at Hull on 20th &21st July
🌟Stellar Faculty
🌟Practical #IBD care tips
🌟Hot topics in #IBD
🌟Great debates

Do register free.
https://t.co/4ZO9eAytyS

[Zeinab Bakhshi MD @z_bakhshiii]

This feels like one of those rare moments that will be remembered for years. A historic achievement in oncology.
🎗👌
Thank you for sharing @marklewismd

[Phillip Gu @DrPhil_Gu]

Tested out in #IBD clinic today. Saw pt with IBD-PSC. Asked when next colonoscopy should be and @EvidenceOpen did not detect that he had PSC

[Aimen Farooq @AimenKhanMD]

@MondayNightIBD @DLeVine901 @GutMD_ #IBDAlgorithm

🧬VEO-IBD
💭Think monogenic disease, esp.
🦠Recurrent infections
🍑Severe perianal Dx.
🚩 Growth failure
🧪 Genetic testing guides precision therapy & identify HSCT candidates early.
🎯 Diagnose first, then treat.

🗳️PostConvo polls👇(Answers in #IBDAlgo😉)

[Beatriz Gros @Bealoquebea]

If you are subscribed to https://t.co/4V0xhhdIti you will receive after a long time an email!
🚀 Big news! https://t.co/4V0xhhdIti has been reinvented

I’ve transformed the platform into a powerful, intuitive content database to make finding IBD drugs, trials, and evidence easier
What’s new?
• A smart, searchable database 🔍
• Easier organization and classification method
• 15+ new clinical trial summaries📚
• Updated cheat sheets 🧠
👇
#IBD #CrohnsDisease #UlcerativeColitis #Gastroenterology #MedEd

[Tauseef Ali MD, FACG AGAF FACP @ibdtweets]

Important discussion with everydayhealth along with my colleague @JessPhilpottMD on one of the evolving frontiers in inflammatory bowel disease care: advanced combination therapy, also known as biologic stacking.
For selected patients with refractory Crohn’s disease, perianal fistulas, or significant extraintestinal manifestations, combining targeted therapies may represent a future precision medicine approach. But important questions remain around long-term safety, cost, access, and insurance approval.
Appreciate the opportunity to share thoughts on where the field may be heading.
What combination strategies in IBD do you think hold the most promise in the coming years?

@SSMHealth @ClevelandClinic @MRegueiroMD

https://t.co/FnxWGvQrPC

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New - Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method study

https://t.co/uxmwqFD0a3

#GITwitter #MedTwitter

[AJG - The American Journal of Gastroenterology @AmJGastro]

Comparative Safety of Advanced Therapies in Patients With Ulcerative Colitis: An Administrative Claims-Based Study
Ahuja, et al.

📕 https://t.co/OWaEoyqIBb

@vipuljairath @MLongMD @JasmohanBajaj

[Maia Kayal MD @MaiaKayalMD]

Lights, camera, awareness 🎬💜 Spending #WorldIBDDay with @pedsIBDdoc talking about the IBD research and education. Thanks for having us #PSLGroup!

[Shrinivas Bishu @IBDimmunology]

2 comments & would love to hear takes @EdBarnesMD @MaiaKayalMD @phillyIBDdoc.

1. Generally - it seems biologics work for CDLP >> pouchitis. BUT -the opposite for abx.

2. This study adjusted for factors- I’m curious if # of prior tx is THE 🔑 factor?

[Freddy Caldera, DO, PhD @dr_fcalderaibd]

Checking VZV serology in patients with #IBD before immunosuppression? Our new @AmJGastro study shows commercial assays frequently miss existing immunity. Take-home: vaccination history > serology. #GITwitter @NASPGHAN @caldera_labIBD @AmCollegeGastro
https://t.co/GsAuuDJm18

[Tauseef Ali MD, FACG AGAF FACP @ibdtweets]

DDW 2026 delivered another exciting year for the IBD community with major updates in disease modification, oral immunology, fistulizing Crohn’s disease, and combination therapy.

Through IBD Library™, we are excited to launch a new educational series:

“Presenting Author’s Top 5 Picks from DDW 2026”

The first edition features top abstract picks from : @AsadurRahman87 Asad ur Rahman MD, Director Inflammatory Bowel Disease Center, Cleveland Clinic Florida.

Concise, practical, and clinically relevant insights from DDW 2026.

IBD Library™

@AmerGastroAssn @DDWMeeting @CCYANetwork @gastroendonews
@IBDProNews @Y_ECCO_IBD
@YOGI_IBD @MondayNightIBD

https://t.co/4vPyeFVCpv

[Stefan Holubar MD MS @HolubarStefan]

Very proud to announce #GoLive!!

#PouchTrilogy is live & open for beta testing 🎉 +

🔬 https://t.co/rj0RYP4ZDs — our #IPAA Consortium to

📚 https://t.co/kEHoGM3aHK — AI interface to >10K pouch articles, evidence-based answers

🩺 https://t.co/zNcRgH265Y — same, patient-facing

[Vraj P. Shah, MD @ShahVrajP]

Which ulcerative colitis patients receive colectomy?

At #DDW2026, we analyzed 700K+ hospitalizations:
📊 Decreased rates in female & Black patients
📊 Increased rates with private insurance
🚨 Racial disparities greatest in emergent admissions
⚖️ Equity in UC remains critical

[Tauseef Ali MD, FACG AGAF FACP @ibdtweets]

Lesson: The combination isn't a blanket winner over guselkumab alone, but the ≥2 prior therapy failure subgroup is the real clinical target and that's where the additive effect of dual IL-23 + TNF blockade becomes apparent.
Perhaps, mirrors the immunological logic: the more refractory the disease, the more likely multiple pathways are driving inflammation simultaneously, and the greater the potential benefit from dual targeting

More to learn !!!

Thanks for sharing @EdwardLoftus2 #DDW2026
@Bealoquebea @DCharabaty

[Uma Mahadevan @UmaMahadevanIBD]

What happens to the gut during pregnancy? Great summary from Satish Rao @DDWMeeting @PIANOIBD